Advertisement
Screener

Aligos Therapeutics, Inc. (ALGS) Auditor

Aligos Therapeutics, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-05: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Francisco, California.
  • 2025-03-10: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2024-03-12: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
  • 2023-03-09: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Mateo, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-052025-12-31Ernst & Young LLP42San Francisco, CaliforniaNo
2025-03-102024-12-31Ernst & Young LLP42San Mateo, CaliforniaNo
2024-03-122023-12-31Ernst & Young LLP42San Mateo, CaliforniaNo
2023-03-092022-12-31Ernst & Young LLP42San Mateo, CaliforniaNo
2022-03-102021-12-31Ernst & Young LLP42Redwood City, CaliforniaNo
2021-03-232020-12-31Ernst & Young LLPRedwood City, CaliforniaNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Alector, Inc. (ALEC)United States$0.213B-1.90
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22